news
Pharma ‘HTS’ the Mark with Screening
21 July 2010 | By NG Online News
Back in May, it was announced that new stem cell research would reduce the need for animal testing...
List view / Grid view
Novartis
news
Outsource to Europe
2 July 2010 | By NG Online News
The pharmaceutical industry has faced well documented challenges over the last 12 months, such as the Pfizer...
news
Novartis data at ECFS
17 June 2010 | By CCA on behalf of Novartis
Data presented at the ECFS Conference in Valencia demonstrate that TIPTM* is as effective as the current standard of care...
news
New analyses demonstrate Novartis Onbrez® Breezhaler® (indacaterol) significantly reduces COPD patient need for ‘relief’ medication
18 May 2010 | By
New analyses of data pooled from the indacaterol Phase III program that led to approval in the EU...
article
Maximising the efficiency and application of automated planar patch clamp electrophysiology
21 September 2007 | By Paul J Groot-Kormelink PhD, Pamela R Tranter PhD and Martin Gosling PhD, Novartis
The widespread expression of ion channels and their ability to significantly modulate cell function makes them attractive drug targets1. Therapeutic agents which target ion channel proteins comprise the third best selling class of prescription drugs with US sales in 2002 estimated at $12 billion. Somewhat surprisingly the discovery of many…
article
Process Analytical Technologies (PAT) in the pharmaceutical industry
European Pharmaceutical Review brings you a comprehensive guide to the current developments and possible future innovations within Process Analytical Technologies...
